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In Parkinson’s disease, visual dysfunction is prominent. Visual hallucinations can be a major hallmark of late stage disease, but
numerous visual deficits also occur in early stage Parkinson’s disease. Specific retinopathy, deficits in the primary visual path-
way and the secondary ventral and dorsal pathways, as well as dysfunction of the attention pathways have all been posited as
causes of hallucinations in Parkinson’s disease. We present data from patients with Parkinson’s disease that contrast with a
known neuro-ophthalmological syndrome, termed ‘blindsight’. In this syndrome, there is an absence of conscious object iden-
tification, but preserved ‘guess’ of the location of a stimulus, preserved reflexive saccades and motion perception and preserved
autonomical and expressive reactions to negative emotional facial expressions. We propose that patients with Parkinson’s
disease have the converse of blindsight, being ‘blind to blindsight’. As such they preserve conscious vision, but show erroneous
‘guess’ localization of visual stimuli, poor saccades and motion perception, and poor emotional face perception with blunted
autonomic reaction. Although a large data set on these deficits in Parkinson’s disease has been accumulated, consolidation into
one specific syndrome has not been proposed. Focusing on neuropathological and physiological data from two phylogenetically
old and subconscious pathways, the retino-colliculo-thalamo-amygdala and the retino-geniculo-extrastriate pathways, we pro-
pose that aberrant function of these systems, including pathologically inhibited superior colliculus activity, deficient corollary
discharges to the frontal eye fields, dysfunctional pulvinar, claustrum and amygdaloid subnuclei of the amygdala, the latter
progressively burdened with Lewy bodies, underlie this syndrome. These network impairments are further corroborated by the
concept of the ‘silent amygdala’. Functionally being ‘blind to blindsight’ may facilitate the highly distinctive ‘presence’ or
‘passage’ hallucinations of Parkinson’s disease and can help to explain handicaps in driving capacities and dysfunctional
‘theory of mind’. We propose this synthesis to prompt refined neuropathological and neuroimaging studies on the pivotal
nuclei in these pathways in order to better understand the networks underpinning this newly conceptualized syndrome in
Parkinson’s disease.
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Introduction
Numerous visual complaints and deficits have been reported in
patients with Parkinson’s disease, ranging from blurred vision to
impairments of contrast and colour discrimination, reduced recog-
nition of facial expression, impaired motion detection and all kinds
of visual illusions and hallucinations. These deficits have been
thought to be due to circumscribed Parkinson’s disease-related
lesions, such as specific retinopathy, burdens of Lewy body in
the striate or extrastriate visual cortex, and medication-induced
effects (Archibald et al., 2009; Bodis-Wollner, 2009; Diederich
et al., 2009). It has been suggested that the deficits affect both
the ventral and the dorsal visual pathways. However, no further
conceptualization has been proposed. The present essay presents
clinical and neuropathological arguments in support of selective
impairment of the visual capacities of patients with Parkinson’s
disease, controlled by neural networks previously studied to ex-
plain ‘blindsight’ syndrome. It postulates that patients with
Parkinson’s disease are ‘blind to blindsight’. Indeed, contrasting
with (relatively) intact neocortical visual pathways, patients with
Parkinson’s disease show dysfunctional blindsight visual pathways,
including dysfunctional saccades, deficient motion perception and
impaired emotional face perception. From this perspective,
Parkinson’s disease might actually be a unique opportunity to
study isolated ‘pure’ conscious vision mediated by the circuit invol-
ving the lateral geniculate nucleus, the primary visual cortex and
the extrastriate visual areas. Importantly, blindsight vision is also
used by normal viewers, but difficult to study (Hesselmann et al.,
2011), because in the conscious sighted persons features of blind-
sight vision are masked by features of conscious vision, with the
predominant pathway connecting the lateral geniculate nucleus to
primary visual cortex, and from there to the extrastriate higher
visual areas.
The blindsight syndrome
Historical perspective
Weiskrantz coined the term ‘blindsight’ after extensive studies of
the retained visual capacities in a patient having had bilateral oc-
cipital damage (Weiskrantz, 1986). Based on his findings, blind-
sight has been considered to be a phenomenon in which people,
who are perceptually blind in a certain area of their visual field,
nevertheless demonstrate intact responses to visual stimuli in that
field, thus suggesting a residual network of functions left undis-
turbed by the cortical lesion (Weiskrantz, 1974, 1996; Stoerig and
Cowey, 1997). A more concise definition by Barbur (2004) states
that ‘blindsight describes the ability to make accurate use of visual
information in the absence of conscious visual perception’. The
components of the blindsight syndrome defined in this purely clin-
ical way are variable, as affected patients have cortical lesions
differing in size and location. However, in patients with hemi-
spherectomy, the archetypal syndrome has been highly consistent,
thus allowing the development of a precise framework for ana-
tomical and physiological characterization of the blindsight
syndrome.
Classical blindsight syndrome
Several visual properties characterize the blindsight syndrome.
First, patients who perceive themselves as blind and therefore
are unable to consciously see visual stimuli, are still able to accu-
rately guess or localize by hand or eye-movement the location
and, rarely, even the identity of stimuli presented in their blind
field (Stoerig and Cowey, 1997). Second, reflexive saccades and
smooth pursuit occur when a tracking object is presented in the
blind visual field, despite the perceived inability to see it. Thus their
‘eyes move with a moving visual scene’ (Stoerig and Cowey,
1997).
New addition: affective blindsight
Blindsight patients appropriately respond, both expressively and by
autonomic testing to emotional facial expressions, especially those
expressing fear or danger (‘affective blindsight’). This latter blind-
sight feature, although not described by the original authors, has
recently been outlined by Tamietto and de Gelder (2010) and
Tamietto et al. (2010), who emphasized that there is overlapping
of subcortical pathways for vision and emotion and that rapid,
subconscious appreciation of emotional face expression is also
used by the visually intact subject (De Gelder et al., 2005;
Tamietto et al., 2009; Tamietto and de Gelder, 2010). In this
essay, we include affective blindsight as the third element of a
blindsight triad.
Blindsight variants
Several authors (Danckert and Rossetti, 2005; Ptito and Leh,
2007) have classified blindsight vision into: (i) action blindsight:
the residual capacity for adequate oculomotor behaviour (pointing
or grasping of blindfield stimuli); (ii) attention blindsight: the re-
sidual capacity of covert spatial orienting and motion detection;
and (iii) agnosopia: the persistent ability to correctly guess percep-
tual characteristics (wavelength, texture, form).
The (correct) above-chance discrimination of certain visual fea-
tures, in the absence of any conscious awareness, has also been
termed ‘blindsight type 1’, whereas in the ‘softer variant’ of ‘blind-
sight type 2’, the patient has a vague feeling that something has
occurred (Weiskrantz, 1996).
Pathophysiology
Achromatic or only S-cone
independent vision?
The blindsight triad is usually mediated by achromatic stimuli so
that there is no perceptual preference of a single visual wave-
length band. However, animal work on lower order mammals
and reptilians suggests that selective wave-length bands may be
an inherent part of blindsight. Thus, in frogs, which rely on a
dichromatic visual system, tectal fibres are specifically driven by
red-sensitive receptors (Maximov et al., 1985). Recent research on
blindsight in humans supports the retention of this reptilian-like
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colour encoding program, with the human superior colliculus being
only insensitive to S-cone (blue-yellow) colour inputs, but still sen-
sitive to other wave-length colours (Leh et al., 2006b, 2010). Also,
in patients with hemi-field blindsight, the pupils continue to react
selectively to red stimuli, even when the stimulus is isoluminant
and entirely restricted to the blind hemi-field (Barbur et al., 1999).
Two separate pathways
Blindsight functions are processed by two pathways, with neither
targeting the primary visual cortex area that plays a critical and piv-
otal role in visual awareness (Figs 1 and 2). The first pathway, termed
the retino-colliculo-thalamo-amygdala (RCTA) pathway, targets the
amygdala, running through the superior colliculus and thalamic relay
stations. The second pathway, named the retino-geniculo-extrastri-
ate (RGES) pathway, connects the retina through the lateral genicu-
late nucleus to the extrastriate ipsilateral visual cortex, namely the
motion area V5/MT in the medial temporal lobe. It constitutes the
unconscious part of the dorsal ‘where’ stream, whereas the conscious
counterpart passes through the primary visual cortex before reaching
the V5/MT area. For the purpose of this essay, we use the term
‘blindsight pathways’ for both blindsight-mediating circuits.
Although initially the exact anatomy of the involved pathways
could only be hypothesized based on lesion studies, functional MRI
and diffusion tensor imaging (Leh et al, 2006a, 2010; Schmid et al.,
2010; Hesselmann et al., 2011) have recently been used to precisely
delineate the pathways underpinning the unconscious visual discri-
mation capacities preserved in blindsight. Diffusion tensor imaging
and transcranial magnetic stimulation in patients with blindsight have
also shown that after several decades such patients demonstrate
some neuroplasticity by ‘reopening’ direct transcallosal pathways
between both V5/MT areas, thus bypassing the usual visual path-
ways. In unaffected controls these latter pathways seem to be ‘ves-
tigial’ at best (Bridge et al., 2008; Ress, 2008; Silvano et al., 2009).
Nuclei involved
In blindsight pathways, four nuclei are all directly implicated.
Superior colliculus
The superior colliculus is not only responsible for subconscious guid-
ance of eye movements, it also informs several brain regions about
the on-going eye movement. It has a layered structure. Whereas the
top layers receive primary inputs from the retina and are organized in
a topographical manner, the deeper layers contain cells with eye
movement properties and induce saccadic eye movements (Schiller
et al., 1972; Wurtz and Goldberg, 1972). The superior colliculus also
receives numerous feedback stimuli from the basal ganglia and the
frontal visual eye fields, among others (McHaffie et al., 2005).
Corollary discharges from the superior colliculus to different brain
regions are essential to guarantee the stability of the visual field.
Thus, in monkeys, pathways running from the superior colliculus (i)
through the medial dorsal nucleus of the thalamus to the frontal eye
fields; and (ii) through the pulvinar nucleus of the thalamus to par-
ietal and occipital cortex, have been identified. By providing infor-
mation about the impending saccade to these regions, these
corollary discharges contribute to visual stability (Sommer and
Wurtz, 2008; Wurtz et al., 2011). Conversely, feedback pathways
from the frontal eye fields to the superior colliculus are involved in the
execution and correction of the saccades, once the decision has been
taken by the superior colliculus ‘about where to look and where not
to look’ (Schiller et al., 2001, 2005). Recordings from the superior
colliculus in monkeys adequately predict if a Go or No-Go decision
will be executed (Hasegawa et al., 2006). Usually, the basal ganglia
tonically inhibit the superior colliculus, but disinhibition is required for
saccade initiation. The closed-loop interaction between both regions
handles visual information selectively, using the following visual par-
ameters: achromatic or S-cone (blue–yellow) independent stimuli,
motion stimuli, differential consideration of the upper and lower
visual field (Comoli et al., 2003; McHaffie et al., 2005; Coizet
et al., 2009; Schulz et al., 2009; Leh et al., 2010). By processing
and selecting the biological salience of targets, the superior colliculus
induces presaccadic short-latency activations of striatal spiny neu-
rons (Schulz et al., 2009). Furthermore, for the effective function
of the superior colliculus, the two-way connections with the frontal
eye fields are a prerequisite in that the superior colliculus activates the
frontal eye fields in the preparatory phase of visual perception, and
the frontal eye fields send an excitatory signal to the superior collicu-
lus when initiating a gaze shift to a target (Dommett et al., 2005;
McHaffie et al., 2005). Dysfunctional interplay within these loops
underlies saccade abnormalities in Parkinson’s disease (see below).
In summary it can be argued that the superior colliculus functions as a
pivotal ‘gate keeper’ to and from the basal ganglia and the frontal
eye fields.
Ventral intralaminar layers of the lateral geniculate
nucleus
The ventral intralaminar layers of the lateral geniculate nucleus are
pivotal relay stations of the RGES pathway, running from the
retina to the extrastriate V5/MT area, which is responsible for
motion detection (Schmid et al., 2010). These ventral layers
have to be differentiated from the dorsal layers functioning as a
relay station to the primary visual cortex.
Pulvinar
The pulvinar mediates information from the superior colliculus to
both the striatum and the amygdala, thus it is also implicated in
processing behaviourally salient visual targets (Day-Brown et al.,
2010).
Amygdala
The amygdala is the end station of the RCTA but also part of the
phylogenetically old fear system. It plays an essential role in emo-
tional arousal (Masaoka et al., 2003).
Evolutionary aspects
The blindsight pathways are highly functional in fish, amphibians,
and reptiles and are operational in human newborns (Braddick
et al., 1992). Essential organizational characteristics of these phylo-
genetically old loops are well preserved in the primate brain, with the
superior colliculus being considered to be the mammalian homo-
logue of the optic tectum of the reptiles (McHaffie et al., 2005).
Of note, blindsighted monkeys hardly show any impairment in
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Figure 1 Schematic representation of the visual pathways. Beside the conscious geniculo-striate pathway (dashed lines), there are two
subconscious visual pathways that do not pass through V1: the RCTA (dashed/dotted lines) and the RGES (closely spaced dotted lines). Of
note, the discussed extension of the RCTA to the amygdala is not represented in the figure. For further explanations see text from
Danckert and Rossetti (2005); with permission. LGN = lateral geniculate nucleus; SC = superior colliculus.
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routine tasks (Cowey and Stoerig, 1995, 1997). Blindsight mediated
by the RCTA handles vitally essential visual information. Through the
covert circuitry to the amygdala it allows ‘expedient detection’ and
‘faster processing’ of fear-related cues, which ‘could aid speedy, sur-
vival-enhancing responses to danger’ (Vuilleumier et al., 2003).
Indeed, the latencies of this essentially magnocellular pathway,
highly sensitive to low spatial frequencies, are shorter than those of
the retino-geniculate-primary visual cortex pathway mediating con-
scious vision. Evidently, in healthy humans this alarm-system pre-
rogative of the RCTA is difficult to prove and with current
technology, its functions are impossible to disentangle from super-
imposed, conscious, forebrain-induced visual responses (Goodale
and Milner, 1992; Crick and Koch, 1995).
The blind to blindsight syndrome in
Parkinson’s disease
For a comparison of blindsight vision and blind to blindsight syn-
drome, see Table 1.
Inappropriate guessing of stimuli in the
peripheral visual field
Blindsighted patients adequately ‘guess’ without consciously per-
ceiving objects, especially moving ones, in their peripheral visual
field. In contrast, patients with Parkinson’s disease are particularly
prone to inaccurate guessing and to misinterpretation of periph-
erally located visual stimuli, experiencing illusions and hallucin-
ations in the peripheral visual field. As such, they often
erroneously guess that there may be moving beings in their lateral
visual field (sensation de passage) or static beings in their sur-
roundings (sensations de presence) (Fe´nelon et al., 2000). In a
first study on 116 consecutive patients with Parkinson’s disease
specifically addressing minor psychotic symptoms (sense of pres-
ence, visual illusions, or passage hallucinations) (Fe´nelon et al.,
2010), these symptoms were present in 45% of the patients.
Thirty-three patients reported sense of presence hallucinations
and 16 passage hallucinations. In the largest published cohort to
date (n = 250 non-demented patients with Parkinson’s disease)
(a) (b)
Figure 2 Cortical and subcortical pathways for vision and emotion. (a) The primary visual pathway (shown by thick arrows) originates
from the retina and projects to the primary V1 in the occipital lobe via an intermediate station in LGN of Th. From V1, visual information
reaches the extrastriate cortex along the ventral (occipitotemporal) and the dorsal (occipitoparietal) stream. However, a minority of fibres
originating from the retina take a secondary route (shown by thin arrows) and reach both SC and Pulv. These two subcortical sites are
connected and also send direct projections to the extrastriate visual cortex, bypassing V1. Another V1-independent visual pathway
consists of the direct projections between the superior colliculus and LGN that, in turn, send efferents to extrastriate cortices in the dorsal
stream. (b) The ‘emotion system’ includes several cortical and subcortical areas. Among the subcortical structures are AMG and SI (shown
in green), which are buried deeply in the temporal lobe and in the basal forebrain, respectively, NA in the basal ganglia (shown in green)
and brainstem nuclei (shown in yellow), such as PAG and LC. Among cortical areas (shown in red) are OFC and ACC. The visual and
emotional systems are extensively interconnected, especially at the subcortical level, where the superior colliculus is connected to the
amygdala via the pulvinar. Direct connections also exist between subcortical and cortical emotion regions (for example, between the
amygdala and OFC or ACC), between subcortical structures for emotions and cortical visual areas (for example, between the amygdala
and temporal cortex) (not shown) and between brainstem nuclei and the cortex via diffuse projections (shown only from the LC). Grey
arrows indicate connections within the emotion system. ACC = anterior cingulate cortex; AMG = amygdala; LC = Locus coeruleus;
LGN = lateral geniculate nucleus; NA = nucleus accumbens; OFC = orbitofrontal cortex; PAG = periaqueductal grey; Pulv = pulvinar;
SC = superior colliculus; SI = substantia innominata; Th = thalamus; V1 = primary visual cortex.
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(Mack et al., 2012), minor psychotic phenomena were seen in 51
patients (20.4%). These were isolated symptoms in 31 patients
(12.4%). Passage hallucinations (45 patients) were twice as fre-
quent as presence hallucinations. Other studies with no clear dis-
tinction of the different phenomena have prevalence rates up to
72% (Williams et al., 2008). Further exploration of the feeling of
presence clearly confirms the projection of the sensation into the
extrapersonal space and also demonstrates the frequent co-occur-
rence of illusions as well as elementary or complex visual hallucin-
ations, thus sustaining its hallucinatory nature (Fe´nelon et al.,
2011). These phenomena have been attributed to side-effects of
the dopaminergic treatment in the context of advancing
Parkinson’s disease (Bulens et al., 1986). It is possible that exces-
sive dopaminergic stimulation (possibly already at the retinal level)
causes inappropriate signalling of the RGES pathway, thus giving
rise to erroneous perception of motion in the peripheral visual
field. To confirm or reject this information, foveation of the per-
ipheral perception is required, but in Parkinson’s disease, the ob-
ligate pursuit saccade is difficult to initiate (see below).
Disturbance of the receptive visual field may further enhance
the erroneous, subconscious predilection for perception of stimuli
in the peripheral visual field. Indeed, during daytime, patients with
Parkinson’s disease experience decreased surround inhibition of
their receptive visual fields, which mimics the visual properties of
light sensitive, wide-angle night vision, enlarging the visual region
of interest to include the peripheral visual fields (Bodis-Wollner
and Tzelepi, 1998).
Inadequate saccades and deficient
motion perception
Blindsighted patients unconsciously detect moving objects and
follow them with adequate pursuit movements, or even grasp
them. In contrast, patients with Parkinson’s disease have difficulty
in rapidly detecting moving objects in their lateral visual field and
in visually following them (Trick et al., 1994). Indeed visually trig-
gered saccades are hypometric in Parkinson’s disease and the
target is often only reached after several saccades (fragmentation
of gaze shifts) (Terao et al., 2013). This excessive hypometria
occurs independently of the adaptation direction (centropedal or
centrifugal) (MacAskill et al., 2002). Memory-guided saccades are
less accurate and difficult to initiate. In the classical model on
Parkinson’s disease pathophysiology by Alexander and Crutcher
(1990), this impaired initiation is due to increased activity of the
inhibitory indirect dopaminergic pathway. As volitional saccades,
memory-guided saccades rely on a correct internal representation
of the movement pattern and are accessed to recheck a visual
stimulus (Terao et al., 2013). Dopaminergic treatment facilitates
planed eye movements and also suppresses paradoxical fast
‘reflexive’ saccades, although the contrary, coined superior collicu-
lus dyskinesia, has also been reported (Cubizolle et al., 2013).
These findings support the concept that the superior colliculus,
pivotal for ‘blindsight’ and instrumental for visuomotor coordin-
ation, is the dysfunctional ‘bottleneck of saccades’ in Parkinson’s
disease (Terao et al., 2013): visually guided saccades are impaired
due to increased inhibition of the superior colliculus through ex-
cessive basal ganglia output and memory-guided saccades are im-
paired due to dysfunctional frontal cortex—superior colliculus
circuitries. Paradoxically, hypermetric reflexive saccades can also
occur in Parkinson’s disease, when the inhibition of the superior
colliculus becomes ‘leaky’ (Sauleau et al., 2008; Terao et al., 2011,
2013). It can be concluded that, independent of the trigger mech-
anism (internal or external), saccades are dysfunctional in
Parkinson’s disease, due to hypometria (mostly) or hypermetria,
delayed initiation, or even inadvertent elicitation. In conjunction
with prolongation of fixation, a disease-specific impact on the
Table 1 Comparing blindsight vision and blind to blindsight syndrome
Function/property Patients with blindsight Patients with Parkinson’s disease
with blind to blindsight
Pathway Nuclei/regions involved
Motion perception Correct ‘guess’ (without
conscious vision) of moving
objects in the peripheral field
Misinterpretation of peripheral
stimulus
Erroneous guess of moving subjects
in the peripheral visual field
(sensations de passage)
RGES Superior colliculus
Ventral intralaminar layers of
the lateral geniculate
nucleus
Extrastriate V5/MT area
Reflexive saccades
and pursuit
Correct reflexive saccades and
smooth pursuit when
tracking objects are
presented in the blind
hemi-field
Hypometric reflexive saccades
Fragmentation of gaze shifts
No correct updating of saccadic size
with new visual information
Slowness of the saccades
Prolonged fixation time
RGES Idem plus frontal eye fields
Emotional face
recognition and
reaction to it
Correct expressive and
autonomic reaction to
(negative) facial emotions
Deficient or delayed emotion face
recognition
Blunted emotional reaction
Secondary hypomimia
Impaired Theory of Mind
RCTA Amygdala
Pulvinar
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networks directing visual exploration has been postulated
(Archibald et al., 2013).
To highlight the comprehensive dysfunction in place, Bodis-
Wollner (2008) and Javaid et al. (2010, 2012) successfully applied
the concept of pre-emptive perception to visual impairment, and in
particular, to saccade impairment in Parkinson’s disease. Even before
definitely knowing what the goal of a perception will be, pre-emptive
perception covers all mechanisms in place by which the voluntary
perception of this eventual target is, first prepared and, later, moni-
tored during its execution. Patients with Parkinson’s disease show
impairment both at the level of pre-attentional visual processing
(Lieb et al., 1999), and later at the level of saccade execution.
Beyond the superior colliculus, functional MRI demonstrates
hypoactivation of the frontal eye fields in patients with
Parkinson’s disease during the preparatory phase of voluntary sac-
cades (Rieger et al., 2008). Furthermore, missing intrasaccadic
gamma synchronization leads to a lack of modulatory coupling
between frontal and posterior mechanisms in patients with
Parkinson’s disease (Javaid et al., 2012). Thus, ‘a frontal neuronal
circuitry, underlying saccade direction selection is deficient’ (Rieger
et al., 2008). However, underlying pathophysiology refers again to
the superior colliculus as it connects both anterior oculo-motor and
occipital visual regions by a corollary discharge when an eye
movement is initiated (Sommer and Wurtz, 2008; Javaid et al.,
2012). The disease-inherent hypoactivation of the frontal eye
fields can be reversed by adequate dopaminergic treatment, at
least in monkeys with MPTP-induced parkinsonism (Ho et al.,
1988). Hyperactivation of the frontal eye fields, as elucidated in
a kinematic paradigm in patients with Parkinson’s disease with
visual hallucinations (Stebbins et al., 2004) probably results from
inadequate dopaminergic overstimulation.
The excessive inhibition of the superior colliculus is directly due to
the overactive substantia nigra pars reticulate. In non-human pri-
mates electrical stimulation of the substantia nigra pars reticulata
replicates this impairment, with reduction in velocity and amplitude
of both visually or memory-triggered saccades by this procedure
(Basso and Liu, 2007). Conversely, reduction of the substantia
nigra pars reticulata inhibition, as achieved by deep brain stimulation
of the nucleus subthalamicus has the reverse effect, as shown in
several studies (Rivaud-Pe´chaux et al., 2000; Yugeta et al., 2010;
Nilsson et al., 2013). In the largest study (Yugeta et al., 2010), 32
medicated patients with Parkinson’s disease were studied in the deep
brain stimulation-on condition; the delay for saccade initiation was
shorter for both visually and memory guided saccades, and the amp-
litude was shorter for visually guided saccades. In a smaller study a
similar favourable impact of deep brain stimulation treatment on
saccade amplitude accuracy was observed after complete with-
drawal of the medication (Nilsson et al., 2013). These studies suggest
that, indeed, dysfunctional activation of the superior colliculus
underlies saccadic abnormalities in Parkinson’s disease.
Deficient negative emotional face per-
ception and blunted autonomic reaction
Blindsighted patients appropriately respond, both expressively and
by autonomic testing, to emotional facial expressions, especially
those expressing fear or danger. In contrast, patients with
Parkinson’s disease are impaired in these same facial emotion rec-
ognition performances. In a pioneer study, Sprengelmeyer et al.
(2003) showed that there is evidence of impaired recognition of
facial expressions in both medicated and unmedicated patients
with Parkinson’s disease. This impairment concerned the recogni-
tion of the facial emotion expressions disgust, fear and anger.
Other authors have confirmed the trend of impaired recognition
of especially negative emotional face expressions and pointed out
that, in comparison to controls, patients with Parkinson’s disease
use different perceptual processes and cognitive strategies during
visual exploration of emotional facial expressions (Pell and
Leonard, 2005; Suzuki et al., 2006; Assogna et al., 2008; Clark
et al., 2008, 2010). This deficient perception is not related to
overall disease severity or to depression (Lawrence et al., 2007).
Part of the underlying visual deficit that leads to poor emotional
recognition may relate to reduced low contrast discrimination, a
well-established deficit experienced by patients with Parkinson’s
disease (Bulens et al., 1986; Diederich et al., 2002; Bodis-
Wollner, 2008). Indeed, it has been shown that contrasts contain-
ing low spatial frequencies are crucial for immediate appreciation
of any (dangerous) change of the outside world and for the rapid
processing of emotional face expressions (Vuilleumier et al.,
2003). However, surprisingly, these deficits do not manifest them-
selves similarly, but only sequentially, with reduced performances
of low contrast discrimination appearing first and reduced facial
emotion recognition appearing later (Hipp et al., 2014). Notably,
Sprengelmeyer (2003), while also reporting lower performances in
contrast discrimination in patients with Parkinson’s disease, did not
discuss the potential pathophysiological link with facial emotion
recognition, reported by Vuilleumier (2003) in healthy subjects.
We propose that subjects with Parkinson’s disease lose the ability
to profit from this ‘early warning system’ and consequently show
abnormal or at least delayed responses to facial emotions, while in
contrast, ‘affective blindsight’ is fully operational in patients with
‘blindsight’ vision.
As mentioned above, the superior colliculus is sensitive to both
achromatic and S-cone-isolating stimuli and ‘blindsight’ vision can
partially read red stimuli (Barbur et al., 2004; Leh et al., 2006b).
Patients with Parkinson’s disease show prominent reduced colour
discrimination (Bu¨ttner et al., 1995; Diederich et al., 2002;
Sartucci et al., 2003), even in early and unmedicated stages of
the disease. The luminance pattern electroretinogram of the tritan
axis (blue/yellow spectrum) may show the earliest changes
(Sartucci et al., 2003; Silva et al., 2005), but involvement of this
colour axis is considered to be an independent ageing phenom-
enon, thus irrelevant for the RCTA functioning. In contrast, the
more pronounced deficits along the protan/deutan axis (red/green
spectrum) compromise the RCTA signalling and thus ‘blindsight’
vision. Dysfunction of the RCTA reduces the most efficient ‘expe-
dient detection’ of negative face expressions, forcing the patient
with Parkinson’s disease to rely on a greater number of fixations
when scanning a face of interest (Clark et al., 2010). This more
tedious procedure potentially leads to errors or delayed responses.
Again in contrast to patients with blindsight, patients with
Parkinson’s disease also show reduced autonomic reactions when
viewing emotionally loaded images. A recent physiological study
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demonstrated a reduced amplitude of the emotionally driven
centro-parietal late positive potential in patients with Parkinson’s
disease viewing unpleasant images (Dietz et al., 2013). This study
has echoed reports showing blunted eyeblink startle reactions in
patients with Parkinson’s disease exposed to photos with negative
emotional face content: fear, anger, disgust; or photos showing
cruel scenes (e.g. mutilations) (Bowers et al., 2006; Miller et al.,
2009). In contrast to control subjects, patients with Parkinson’s
disease did not produce more marked responses to images with
higher emotional valence than to images with lower emotional
valence. Reduced sympathetic skin conductance in patients with
Parkinson’s disease viewing faces with negative emotional expres-
sions could possibly only reflect a peripheral deficit, as Lewy body
pathology also occurs in sympathetic ganglia of the skin (Bowers
et al., 2008). Finally, pupillometry has been proposed as a
‘window to the preconscious’ (Laeng et al., 2012) and used for
studying the autonomic reactions to visual stimuli. A small study
did not observe any difference in pupillary dynamics in response to
emotional expressions between patients with Parkinson’s disease
and healthy controls, all viewing emotional face expressions (Dietz
et al., 2011). The results are difficult to interpret, because the
patients with Parkinson’s disease were tested while ON dopa-
minergic medication and half of them were also taking anti-
depressants. Pharmacologically, SNRI (serotonin–norepinephrine
reuptake inhibitors) may have partially compensated for
disease-inherent noradrenergic deficits in pupillary dynamics,
usually mediated by the locus coeruleus (Laeng et al., 2012).
Furthermore, rapid as well as ample, pupillary responses cannot
be expected in patients with Parkinson’s disease as variations in
pupillary diameter in general are reduced and slower than in con-
trols (Micieli et al., 1991). When trying to globally explain these
diminished autonomic reactions, authors have hypothesized on
autonomic hypoarousal due to amygdala dysfunction in
Parkinson’s disease, secondary to dysfunctional RCTA pathway
(Miller et al., 2009). This pathway dysfunction can only be posited
at this point, and specific experiments must be designed to exam-
ine the issue.
Taken together, these data suggest impairment in patients with
Parkinson’s disease of several visual parameters that are generally
preserved within the blindsight visual system, namely detection of
motion in the lateral field, initiation and execution of appropriately
targeted saccades, ‘first glimpse’ rapid visual appreciation of nega-
tive (vitally important?) facial expressions.
Supportive neuropathology and
neuroimaging
We are unaware of any functional MRI study directly exploring
pathways and nuclei specifically involved in blindsight in patients
with Parkinson’s disease. Voxel-based morphometric studies have
only reported a correlation between facial emotion recognition of
sadness and the grey matter volume of the amygdala in
Parkinson’s disease. Correlations between the recognition of dis-
gust and the grey matter volume of the anterior cingulate cortex
have also been reported (Ibarretxe-Bilbao et al., 2009; Baggio
et al., 2012). As mentioned above, neurophysiological data
implicate that in Parkinson’s disease the superior colliculus is con-
stantly inhibited by the basal ganglia, while for adequate visual
guidance, intermittent disinhibition of the superior colliculus would
be required. Beyond this pathophysiological argument for second-
ary involvement of the superior colliculus in Parkinson’s disease,
there are histochemical data documenting excessive inhibition of
the superior colliculus in patients with Parkinson’s disease.
Relevant studies have examined autopsies of patients with
Parkinson’s disease, using the marker for messenger RNA coding
of GAD1. The substantial reduction in GAD1 messenger RNA ex-
pression documented in superior colliculus is probably due to the
assumed hyperactivity of the inhibitory nigrotectal pathway (Vila
et al., 1996).
Extensive neuropathological autopsy data have been reported in
patients with Parkinson’s disease with visual hallucinations. In a
seminal autopsy study on patients with Parkinson’s disease with
hallucinations and with particular emphasis on the amygdala,
Harding et al. (2002) documented that the different amygdala
subnuclei do not show uniform burden of Lewy body, as more
selective involvement with cellular loss and high burden of Lewy
body was seen in the subnucleus called the cortical amygdaloid
nucleus. Other studies have confirmed higher Lewy body burden
in the basal and lateral amygdaloid nuclei, but also in the claus-
trum and the pulvinar (Braak et al., 1994, 2003; Iseki et al.,
2007). In an autopsy study focusing on patients with Lewy body
dementia and visual hallucinations, 15 of 19 patients showed sig-
nificant neuronal cell loss, most marked in the lateral and basal
amygdaloid nucleus (Yamamoto et al., 2006). The same investi-
gators described marked Lewy body pathology in the pulvinar and
claustrum, as well as the insular and inferior temporal cortices.
They reported mild cell loss in the lateral geniculate nucleus and
suggested that dysfunction of both the visuo-claustral and the
visuo-amygdaloid pathway may contribute to visual misidentifica-
tion syndromes in Parkinson’s disease (Yamamoto et al., 2007).
Braak et al. (2003) and Halliday (2009) did not report Lewy body
in the lateral geniculate nucleus, although thalamic nuclei are
prominently affected by the disease process. Based on neuro-
physiological and neuroimaging studies, the concept of the
‘silent amygdala’ has been coined to explain conjoint odour mis-
identification, autonomic disturbances, and visual hallucinations in
patients with Parkinson’s disease (Yoshimura et al., 2005). Indeed,
the amygdala plays an essential role for adequate appreciation of
and body response to the emotional salience of various percep-
tions. In summary neuropathological and neuroradiological litera-
ture provides ample evidence for blindsight pathways’ involvement
in Parkinson’s disease without, however, specifically referring to
blindsight as an underlying concept. Again, these findings contrast
with selective preservation of these unconscious pathways in pa-
tients with blindsight.
Discussion
The proposal of ‘blind to blindsight’ in Parkinson’s disease is in line
with the recently proposed model by Redgrave et al. (2010a, b)
on the pivotal role of the basal ganglia in ‘habitual and goal-dir-
ected’ actions. As proposed by these authors, the predominant
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dopamine loss in the posterior putamen forces patients with
Parkinson’s disease to rely on goal-directed, inherently slower
modes of action. Extended to vision, this model means that
rapid blindsight-mediated visual functions, as outlined above,
have to be replaced by the longer-latency performances of the
neocortical visual pathway. We highlight here a few parkinsonian
features, beyond the hallucinations of ‘passage’ and ‘presence’
already explicitly discussed above, that may result from this blind
to blindsight syndrome and contribute to parkinsonian disability
and diminished quality of life. As alluded to above, the uncon-
scious emotional perception of faces contributes to rapid and in-
tense body reactions, including autonomic responses, respiration
and facial movements; all important to social interactions and
communication (Frith, 2009). It is possible that the marked hypo-
mimia of patients with Parkinson’s disease not only reflects bra-
dykinesia of facial muscles, but also mirrors deficient emotional
reactivity mediated by the RTCA. ‘Theory of mind’, or the ability
to reason about other people’s mental states to explain and pre-
dict their behaviour (Fletcher et al.,1995), both in its affective and
cognitive components, is altered even in early Parkinson’s disease
stages and may not only be due to disturbed fronto-subcortical
circuitries, but also to reduced subconscious appreciation of emo-
tional facial expressions in direct face-to-face interactions (Bodden
et al., 2010; Roca et al., 2010; Narme et al., 2013). The encoun-
tered vehicle driving difficulties of patients with Parkinson’s disease
may not only be mediated by reduced vigilance spans, prolonged
reaction times or deficient decision making, but may also be due
to reduced rapid screening of the peripheral visual field by auto-
matic exploratory saccades, respectively by reduced motion detec-
tion due to malfunction of collicular oculo-motor pathways.
Patients with Parkinson’s disease show deficiencies in exploring
the visual field and score worse than age-matched controls on
measures of visual processing speed, attention and motion percep-
tion. They are particularly handicapped when driving under low-
contrast visibility conditions (Uc et al., 2006, 2007, 2009).
Limitations
The present essay reviews knowledge on visual and visually-
related neurobehavioral symptoms in Parkinson’s disease. We
emphasize that not all visual and ocular deficits encountered in
patients with Parkinson’s disease can be classified within the
new concept. Whereas impaired saccadic and smooth pursuit
can be explained within this paradigm, other restrictions of oculo-
motor movements, such as loss of the convergence reflex and
limitation of the upward gaze (Jankovic, 2003), do not specifically
fit into the present concept. Furthermore, the ‘blind to blindsight’
hypothesis focuses on unconscious visual networks, whereas nu-
merous studies have shown involvement of conscious neocortical
visual pathways, especially in more advanced disease stages. These
studies have focused on freezing of gait and hallucinations, and in
such studies, we consider the concept of segregated visual path-
ways as suggested by Goodale and Milner (1992) to be highly
pertinent. As predicted by that framework, patients with freezing
of gait show involvement of the dorsal visual pathways (Lord
et al., 2012), whereas marked atrophy of numerous regions
involved in both the ventral ‘what’ and the dorsal ‘where’ path-
ways is visible in patients with hallucinations (Goldman et al.,
2014). Atrophy may not only be the consequence of local Lewy
body pathology as predicted by Braak’s hypothesis on ascending
degeneration in Parkinson’s disease, but also a consequence of
pathological deactivation, during or before visual perception
(Meppelink et al., 2009) and, more fundamentally, as part of mal-
functioning of the default mode network (van Eimeren et al.,
2009; Onofrj et al., 2013).
Nonetheless, because so many studies have been conducted
without a specific and consolidating hypothesis on visual dysfunc-
tion in patients with Parkinson’s disease, we offer this ‘blind to
blindsight’ as a new conceptual framework to integrate many
types of visual impairments in Parkinson’s disease. Blindsight has
been posited as a function of ‘phylogenetically old parts of the
brain’ (Widakowich, 2001). Patients with Parkinson’s disease may
suffer from other symptoms due to dysfunction of archaic net-
works, such as loss of gait automatization and hyposmia
(Diederich and Parent, 2012). It is possible that secondary neur-
onal plasticity and network reorganization compensate some of
the encountered deficits due to deficient blindsight; these com-
pensatory changes, while reducing the clinical repercussions of
the syndrome, would also echo the compensatory changes opera-
tive in patients with blindsight (Stoerig and Cowey, 1997; Bridge
et al., 2008). The authors also agree with Tamietto and de Gelder
(2010) that conscious and non-conscious pathways may be ana-
tomically distinct, but not functionally independent, although we
have conceptually done so to unravel the ‘blindsight’ deficit in
patients with Parkinson’s disease. As with any introductory
model, criticisms of simplicity can be lodged, and the authors
accept this very legitimate criticism. Nonetheless, from this
model, testable hypotheses can be developed logically, with
experimental paradigms to confirm or refute these tenets.
Future perspectives and
testable hypotheses
Neuropathological studies focusing on the pivotal areas involved in
‘blindsight’ vision, namely the superior colliculus, lateral geniculate
nucleus and pulvinar have to be encouraged in patients with
Parkinson’s disease. The use of diffusion tensor imaging may be
able to track in vivo the involvement of subcortical pathways in
patients with Parkinson’s disease and controls (Leh et al., 2006a).
The application of transcranial magnetic stimulation over the visual
cortex, with transient blockade of the conscious visual pathways,
without suppression of the non-conscious pathways may also be
an appealing neurophysiological approach (Ro et al., 2004; Jolij
and Lamme, 2005; Allen et al., 2014). By using this technique in
patients with Parkinson’s disease, the extent to which both con-
scious and unconscious pathways contribute and interrelate to
visual dysfunction could be better delineated. Patients with
Parkinson’s disease may actually facilitate fundamental vision re-
search by studying exclusively conscious primary visual cortex-
extrastriate vision without concurrent ‘unconscious’ vision. From
a clinical point of way, prospective studies examining the evolution
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of the blind to blindsight syndrome should explore secondarily
reduced quality of life and other measures of Parkinson’s disease
disability.
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